Concomitant measurements of serum annexin A5 levels and hematological indices as markers in recent and old myocardial infarction with low ejection fraction: A preliminary study

Alhusseiny AH 1 , Al-Nimer MS 2 , Mohammad FI 3 , Ali Jadoo SA 4

Affiliations 

  • 1 Department of Medicine, College of Medicine, Diyala University, Diyala, Iraq
  • 2 Department of Pharmacology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq
  • 3 Biotechnology Research Center, Al-Nahrain University, Baghdad, Iraq
  • 4 International Centre for Casemix and Clinical coding, National University of Malaysia Kuala Lumpur, Malaysia. Electronic address: drsaadalezzi@gmail.com
Int J Cardiol, 2016 Nov 15;223:514-518.
PMID: 27552568 DOI: 10.1016/j.ijcard.2016.08.244

Abstract

Serum annexin A5 (anxA5) level is significantly increased in patients with acute coronary syndrome. Hematological indices are significantly increased in patients with ischemic heart disease. This study aimed to demonstrate the changes in the distribution of blood cells and the levels of anxA5 in patients presented with significant low ejection fraction ST-elevation acute myocardial infarction (STEMI) in comparison with corresponding patients with ischemic heart disease.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications